149 related articles for article (PubMed ID: 10985325)
1. Lessons from lipodystrophy: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophy.
Behrens GM; Lloyd D; Schmidt HH; Schmidt RE; Trembath RC
AIDS; 2000 Aug; 14(12):1854-5. PubMed ID: 10985325
[No Abstract] [Full Text] [Related]
2. Absence of mutations in exon 8 of the gene in combination antiretroviral therapy-associated partial lipodystrophy.
Domingo P; Baiget M; Arroyo JA; Seco L; Sambeat MA; Domenech M; Vazquez G
J Acquir Immune Defic Syndr; 2002 Aug; 30(4):457-8. PubMed ID: 12138353
[No Abstract] [Full Text] [Related]
3. Pushing the envelope on lipodystrophy.
Flier JS
Nat Genet; 2000 Feb; 24(2):103-4. PubMed ID: 10655047
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy.
Hegele RA; Cao H; Anderson CM; Hramiak IM
J Clin Endocrinol Metab; 2000 Sep; 85(9):3431-5. PubMed ID: 10999845
[TBL] [Abstract][Full Text] [Related]
5. Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy.
Vigouroux C; Magré J; Vantyghem MC; Bourut C; Lascols O; Shackleton S; Lloyd DJ; Guerci B; Padova G; Valensi P; Grimaldi A; Piquemal R; Touraine P; Trembath RC; Capeau J
Diabetes; 2000 Nov; 49(11):1958-62. PubMed ID: 11078466
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene.
Garg A; Vinaitheerthan M; Weatherall PT; Bowcock AM
J Clin Endocrinol Metab; 2001 Jan; 86(1):59-65. PubMed ID: 11231979
[TBL] [Abstract][Full Text] [Related]
7. Lack of mutations in LMNA, its promoter region, and the cellular retinoic acid binding protein II (CRABP II) in HIV associated lipodystrophy.
Behrens GM; Genschel J; Schmidt RE; Schmidt HH
Eur J Med Res; 2003 May; 8(5):221-5. PubMed ID: 12844477
[TBL] [Abstract][Full Text] [Related]
8. Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene.
Garg A; Speckman RA; Bowcock AM
Am J Med; 2002 May; 112(7):549-55. PubMed ID: 12015247
[TBL] [Abstract][Full Text] [Related]
9. LMNA messenger RNA expression in highly active antiretroviral therapy-treated HIV-positive patients.
Miranda M; Chacón MR; Vidal F; Megia A; Richart C; Veloso S; Saumoy M; Olona C; Vendrell J
J Acquir Immune Defic Syndr; 2007 Dec; 46(4):384-9. PubMed ID: 18077842
[TBL] [Abstract][Full Text] [Related]
10. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes.
Hegele RA; Anderson CM; Wang J; Jones DC; Cao H
Genome Res; 2000 May; 10(5):652-8. PubMed ID: 10810087
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the LMNA gene encoding lamin A/C.
Genschel J; Schmidt HH
Hum Mutat; 2000 Dec; 16(6):451-9. PubMed ID: 11102973
[TBL] [Abstract][Full Text] [Related]
12. Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy.
van der Kooi AJ; Bonne G; Eymard B; Duboc D; Talim B; Van der Valk M; Reiss P; Richard P; Demay L; Merlini L; Schwartz K; Busch HF; de Visser M
Neurology; 2002 Aug; 59(4):620-3. PubMed ID: 12196663
[TBL] [Abstract][Full Text] [Related]
13. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.
Shackleton S; Lloyd DJ; Jackson SN; Evans R; Niermeijer MF; Singh BM; Schmidt H; Brabant G; Kumar S; Durrington PN; Gregory S; O'Rahilly S; Trembath RC
Nat Genet; 2000 Feb; 24(2):153-6. PubMed ID: 10655060
[TBL] [Abstract][Full Text] [Related]
14. Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy.
Miró O; Gómez M; Pedrol E; Cardellach F; Nunes V; Casademont J
AIDS; 2000 Aug; 14(12):1855-7. PubMed ID: 10985326
[No Abstract] [Full Text] [Related]
15. HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
Goulbourne CN; Vaux DJ
Biochem Soc Trans; 2010 Feb; 38(Pt 1):292-6. PubMed ID: 20074077
[TBL] [Abstract][Full Text] [Related]
16. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
Favreau C; Dubosclard E; Ostlund C; Vigouroux C; Capeau J; Wehnert M; Higuet D; Worman HJ; Courvalin JC; Buendia B
Exp Cell Res; 2003 Jan; 282(1):14-23. PubMed ID: 12490190
[TBL] [Abstract][Full Text] [Related]
17. Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance.
Hegele RA; Anderson CM; Cao H
Diabetes Care; 2000 Feb; 23(2):258-9. PubMed ID: 10868844
[No Abstract] [Full Text] [Related]
18. Antiretroviral therapy-induced lipodystrophy.
Behera V; Randive M; Sundaray S; Murty MS
BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25678613
[No Abstract] [Full Text] [Related]
19. Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
Patni N; Xing C; Agarwal AK; Garg A
Am J Med Genet A; 2017 Sep; 173(9):2517-2521. PubMed ID: 28686329
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
